News
From February 13, FDA In-Person Session To Start Barring Few
FDA has recently announced that it is going to restart its in-person meetings that are face-to-face beginning February 13 with industry sponsors of biologics...
Drug Research
To Curb Medicine Inequality, 3-Year Novel Strategy Announced
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability...
Drug Research
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE).
Dupixent’s expanded authorisation in the...
Drug Research
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s...
Drug Research
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus Vaccine Candidate
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has...
Drug Research
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Eli Lilly and Company announced plans to invest an additional $450 million and create at least 100 new jobs to expand its manufacturing capacity...
Drug Research
SK bioscience introduces new partnership model to establish regional vaccine hubs
SK bioscience, a global innovative vaccine and biotech company, introduced a new global partnership model under the title of ‘Preparing for Next Pandemic through...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read